[Fundamental and clinical studies on cefoperazone in pediatrics, with special reference to renal toxicity]. 1985

A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi

Fundamental, clinical studies on cefoperazone (CPZ), a new synthetic antibiotic of cephalosporins was conducted to obtain results as follows. This preparation, 11.4-50 mg/kg was administered to 11 cases of children by intravenous drip infusion for 30 minutes, and serum levels were studied. The highest serum level at the completion of infusion was 40.0-138.0 mcg/ml. A dose response was observed. The half-life in serum averaged 1.55 hours except 2.4 hours observed with 1 case of liver dysfunction. When the urinary excretion during 30 minutes drip infusion was examined, the urinary recovery rate at 0-6 hours in 2 cases of children averaged 17.2% and was low at 5.3% in 1 case of membranoproliferative glomerulonephritis. In terms of the clinical effect on bacterial infections in pediatric field, CPZ proved effective in all of the 21 cases in which it was used alone. And it showed an excellent antibacterial activity against all the bacteria isolated from cases used as the subjects. When side effects were studied, diarrhea and slight impairment of the liver were observed, but all were transient. As a result of a study on the renal toxicity of CPZ, CPZ was deemed as being a drug which hardly causes disturbance of renal tubules judging from the aspect of the beta-D-N-acetylglucosaminidase activity in urine and variations in the urine beta 2-microglobulin levels.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D002438 Cefoperazone Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections. Cefobid,Cefoperazon,Cefoperazone Sodium,Cefoperazone Sodium Salt,Céfobis,T-1551,T1551,Salt, Cefoperazone Sodium,Sodium Salt, Cefoperazone,Sodium, Cefoperazone,T 1551
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
November 1984, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
November 1985, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
April 1986, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
April 1986, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
April 1985, Hinyokika kiyo. Acta urologica Japonica,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
September 1980, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
August 1980, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
September 1968, Iryo,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
July 1986, The Japanese journal of antibiotics,
A Tanaka, and T Asami, and T Nishihara, and S Tomizawa, and K Sakai, and S Itoh, and R Murai, and Y Kubota, and F Sasagawa, and K Nishi
May 1952, Giornale di scienze mediche,
Copied contents to your clipboard!